YUNNAN BOTANEE BIO-TECHNOLOGY GROUP CO.LTD

Yunnan Botanee Bio-Technology Group Co.LTD

300957

CNE100004G74

Personal Products

End-of-day quote Shenzhen S.E. Other stock markets 03:30:00 12/06/2024 am IST			5-day change	1st Jan Change
52.52 ^CNY	+0.40%		-2.07%	-22.96%

29/04	Jefferies Adjusts Yunnan Botanee Bio-Technology’s Price Target to 62 Yuan From 87 Yuan, Keeps at Hold	MT
25/04	Yunnan Botanee Bio-Technology Group Co.LTD Reports Earnings Results for the First Quarter Ended March 31, 2024	CI

Yunnan Botanee Bio-Technology Group Co.LTD Approves Dividend

May 11, 2022 at 01:03 am IST

Yunnan Botanee Bio-Technology Group Co.LTD approved dividend of CNY 6.00000000 per 10 shares.

Latest news about Yunnan Botanee Bio-Technology Group Co.LTD

Jefferies Adjusts Yunnan Botanee Bio-Technology’s Price Target to 62 Yuan From 87 Yuan, Keeps at Hold	29/04	MT
Yunnan Botanee Bio-Technology Group Co.LTD Reports Earnings Results for the First Quarter Ended March 31, 2024	25/04	CI
Yunnan Botanee Bio-Technology Group Co.LTD Reports Earnings Results for the Full Year Ended December 31, 2023	25/04	CI
Tranche Update on Yunnan Botanee Bio-Technology Group Co.LTD's Equity Buyback Plan announced on August 30, 2023.	01/04	CI
Certain A Shares of Yunnan Botanee Bio-Technology Group Co.LTD are subject to a Lock-Up Agreement Ending on 25-MAR-2024.	25/03	CI
Weimai Medical Technology Co., Ltd. announced that it has received funding from CDH Investment Management Company Limited, Yunnan Botanee Bio-Technology Group Co.LTD	15/03	CI
Weimai Qingtong Medical Technology Co., Ltd. announced that it has received funding from CDH Investment Management Company Limited, Changzhou Lizhong Investment Management Co., Ltd., Yunnan Botanee Bio-Technology Group Co.LTD, Guangdong Evergreen Conglomerate Co., Ltd.	13/03	CI
Tranche Update on Yunnan Botanee Bio-Technology Group Co.LTD's Equity Buyback Plan announced on August 30, 2023.	02/01	CI
In China's slowing beauty market, big brand discounts won't cut it	08/12	RE
Shanghai Weimu Medical Technology Co., Ltd. announced that it has received CNY 100 million in funding from Yunnan Botanee Bio-Technology Group Co.LTD, Huajin Avenue Investment Co., Ltd., SHAREWIN Equity Investment and Management Co., Ltd., Shanghai CS Capital Co., Ltd, Sinvo Capital Holdings Co., Ltd., Investment Arm, IDG Capital Partners Co., Ltd.	06/12	CI
Jefferies Adjusts Yunnan Botanee Bio-Technology’s Price Target to 87 Yuan From 105 Yuan, Keeps at Hold	31/23/31	MT
Yunnan Botanee Bio-Technology Group Co.LTD Reports Earnings Results for the Nine Months Ended September 30, 2023	29/23/29	CI
Yunnan Botanee Bio-Technology Group Co.LTD announces an Increase in Equity Buyback.	27/23/27	CI
Weimai Medical Technology Co., Ltd. announced that it has received funding from Yunnan Botanee Bio-Technology Group Co.LTD	27/23/27	CI
Yunnan Botanee Bio-Technology Group Co.LTD announces an Equity Buyback for CNY 200 million worth of its shares.	30/23/30	CI
Yunnan Botanee Bio-Technology Group Co.LTD authorizes a Buyback Plan.	30/23/30	CI
Yunnan Botanee’s H1 Profit Jumps 14% as Revenue Grows 15.5%	29/23/29	MT
Yunnan Botanee Bio-Technology Group Co.LTD Reports Earnings Results for the Half Year Ended June 30, 2023	28/23/28	CI
Shanghai Ruishi Health Technology Co., Ltd. announced that it has received CNY 100 million in funding from BRV Partners, LLC, Yaojin Private Equity Fund Management Co., Ltd., Sinovation Ventures Enterprise Management Limited, Yunnan Botanee Bio-Technology Group Co.LTD	09/23/09	CI
Yunnan Botanee Seeks to Double Revenue in Three Years	14/23/14	MT
Jefferies Adjusts Yunnan Botanee Bio-Technology’s Price Target to 105 Yuan From 132 Yuan, Keeps at Hold	13/23/13	MT
Jefferies Adjusts Yunnan Botanee Bio-Technology’s Price Target to 132 Yuan From 145 Yuan, Keeps at Hold	28/23/28	MT
Yunnan Botanee Bio-Technology Group Co.LTD Reports Earnings Results for the First Quarter Ended March 31, 2023	26/23/26	CI
Jeffries Downgrades Yunnan Botanee Bio-Technology to Hold From Buy, Adjusts Price Target to 145 Yuan From 200 Yuan	31/23/31	MT
Jefferies Adjusts Yunnan Botanee Bio-Technology Group's Price Target to 200 Yuan From 220 Yuan, Keeps at Buy	26/22/26	MT

Chart Yunnan Botanee Bio-Technology Group Co.LTD

Duration

Period

Chart Yunnan Botanee Bio-Technology Group Co.LTD

More charts

Yunnan Botanee Bio-Technology Group Co LTD is a Chinese company mainly engaged in the production of cosmetics. The Company adopts a sales model based on offline channel sales and online channel sales as the leading factor. The Company's products mainly include creams, skin care lotions, facial masks, essences, lotions and other skin care products and make-up products such as isolation creams, blemish balm (BB) creams, and makeup removers. The Company is also engaged in the research and development, production and sales of skin care-related medical device products, mainly including hyaluronic acid repairing biofilm, hyaluronic acid repairing dressings, mainly used for the protection of skin with damaged barriers after minimally invasive surgery and care.

Sector

Personal Products

Calendar

27/08/2024 - Q2 2024 Earnings Release (Projected)

More about the company

Income Statement Evolution

More financial data

Ratings for Yunnan Botanee Bio-Technology Group Co.LTD

Trading Rating

Investor Rating

ESG Refinitiv

C+

More Ratings

Analysts' Consensus

Sell

Buy

Mean consensus

BUY

Number of Analysts

Last Close Price

52.52 CNY

Average target price

75.99 CNY

Spread / Average Target

+44.69%

Consensus

EPS Revisions

Estimates Revisions

Quarterly earnings - Rate of surprise

Company calendar

Sector Cosmetics & Perfumes

	1st Jan change	Capi.
YUNNAN BOTANEE BIO-TECHNOLOGY GROUP CO.LTD	-22.96%	3.04B
L'ORÉAL	+1.04%	259B
KAO CORPORATION	+16.33%	19.94B
GALDERMA GROUP AG	0.00%	19.32B
SHISEIDO COMPANY, LIMITED	+18.11%	12.88B
COTY INC.	-19.32%	8.53B
AMOREPACIFIC CORPORATION	+32.21%	7.91B
PROYA COSMETICS CO.,LTD.	+9.16%	5.99B
NATURA &CO HOLDING S.A.	-11.84%	3.84B
KOSÉ CORPORATION	+0.24%	3.78B

Cosmetics & Perfumes